Diversified Healthcare Trust DHCNI

Q3 FY2026 · ended Sep 30, 2026 · Revenue $367.67M, -5.4% YoY · Filed Nov 2, 2026

Diversified Healthcare Trust (DHC) files with the SEC under industry code 6798, Real Estate Investment Trusts. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $367.7 million and a net loss of $50.2 million. As of Sep 30, 2026 it held $110.7 million in cash and investments and $2.5 billion in total debt.

Revenue
$367.67M
-5.4% vs year-ago quarter
Net income
$-50.23M
+69.4% vs year-ago quarter
Operating cash flow
$27.39M
+155.6% vs year-ago quarter
Free cash flow
—
EPS
$-0.21
+69.1% vs year-ago quarter
Dividend per share
$0.01
+0.0% vs year-ago quarter
Shares outstanding
242.53M
+0.2% vs year-ago quarter
Net cash
$-2.34B
Q3 FY2026
Operating margin
—

Company profile

Industry
Real Estate Investment Trusts (SIC 6798)
Listed as
DHC (Nasdaq), DHCNI (Nasdaq), DHCNL (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MD
Headquarters
Newton, MA
SEC filer status
Large accelerated filer
SEC CIK
1075415
Former names
SENIOR HOUSING PROPERTIES TRUST (until Nov 7, 2019)

Other Real Estate Investment Trusts companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Revenue
$367.7M
$365.4M
$366.5M
$379.6M
$388.7M
Net income
-$50.2M
-$37.4M
-$43.3M
-$21.2M
-$164.0M
Diluted EPS
-$0.21
-$0.16
-$0.18
-$0.09
-$0.68
Operating cash flow
$27.4M
$38.4M
$8.3M
-$20.1M
-$49.3M
Total assets
$4.2B
$4.2B
$4.3B
$4.4B
$4.7B
Total liabilities
$2.7B
$2.7B
$2.6B
$2.7B
$3.0B
Stockholders' equity
$1.5B
$1.6B
$1.6B
$1.7B
$1.7B
Cash and investments
$110.7M
$116.8M
$121.8M
$105.4M
$201.4M
Total debt
$2.5B
$2.5B
$2.5B
$2.5B
$17.8M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 2, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 2, 2026 Nov 2, 2026
10-Q Quarterly report Aug 3, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 3, 2026 Aug 3, 2026
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 10, 2026
8-K Current report
Regulation FD disclosure
Jun 1, 2026 Jun 1, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.